SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001178913-22-004137
Filing Date
2022-11-23
Accepted
2022-11-23 16:08:41
Documents
13
Period of Report
2022-11-21
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm   iXBRL 8-K 33040
  Complete submission text file 0001178913-22-004137.txt   217561

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA entx-20221121.xsd EX-101.SCH 4677
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE entx-20221121_def.xml EX-101.DEF 18391
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE entx-20221121_lab.xml EX-101.LAB 28710
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE entx-20221121_pre.xml EX-101.PRE 20633
7 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 6879
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38556 | Film No.: 221416416
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences